● Recruiting

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

Condition: Tricuspid Valve Regurgitation · Heart Valve Diseases · Cardiovascular Diseases · Sponsor: Edwards Lifesciences

PhaseN/A

Planned participants500

Who can joinAll sexes, N/A to no upper limit

Healthy volunteersNo

About this study

This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.

This description comes directly from the study's public registry record.

Talk to the study team

TMTT Clinical · +1-949-250-2500 or · TMTT_Clinical@Edwards.com

Always discuss trial participation with your own doctor first.

Locations (2)

Herz-und Diabeteszentrum NRW	Bad Oeynhausen, Germany	Recruiting
Inselspital	Bern, Switzerland	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06569602